SIRT2 and central nervous system cancer: SIRT2 and SIRT4, on the other hand, are considered tumor suppressor, downregulated in glioma and hepatocellular carcinoma (SIRT2) [14,15], and bladder, gastric and lung cancer (SIRT4) [16], among others.